SCHEMBL2940929

SCHEMBL2940929

Fc1ccc(-c2c3c(F)c(F)c(F)c(F)c3c(-c3ccc(F)cc3F)c3c(F)c(F)c(F)c(F)c23)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
IDO1 P14902 2/20 0.36
AGXT P21549 2/20 0.36
TTR P02766 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
DHFR P00374 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
LMNA P02545 1/20 0.36
ALB P02768 1/20 0.36
HMGB1 P09429 1/20 0.36
HPGD P15428 1/20 0.36
CXCL12 P48061 1/20 0.36
KMT2A Q03164 1/20 0.36
HIF1A Q16665 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.36
ACMSD Q8TDX5 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2724713 0.94 ALDH1A1 (0.35) ALDH1A1IDO1AGXTTTRKDM4E
SCHEMBL12086099 0.90 ALDH1A1 (0.33) ALDH1A1IDO1AGXTTTRKDM4E
SCHEMBL6281065 0.90 ALDH1A1 (0.35) ALDH1A1IDO1AGXTTTRKDM4E
SCHEMBL2712494 0.89 ALDH1A1 (0.34) ALDH1A1IDO1AGXTTTRKDM4E
SCHEMBL2712268 0.87 ADORA1 (0.40) ALDH1A1TTRKDM4EMEN1USP2
SCHEMBL2728520 0.86 ALDH1A1 (0.38) ALDH1A1IDO1AGXTTTRKDM4E
SCHEMBL2710390 0.86 ALDH1A1 (0.38) ALDH1A1CA1CA2CA6NR1I2
SCHEMBL6284436 0.86 ALDH1A1 (0.42) ALDH1A1IDO1AGXTTTRKDM4E
SCHEMBL2724504 0.86 KDM4E (0.36) ALDH1A1TTRKDM4EMEN1USP2
SCHEMBL2725518 0.84 ALDH1A1 (0.35) ALDH1A1NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 ALDH1A1 34/4885IDO1 409/4885AGXT 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.